FDA Investigator Daniel Pst Laurent
Daniel Pst Laurent has inspections in 1 countries as of 08 Sep 2023. Daniel Pst Laurent has collaborated with a combinined 2036 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
101
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan M Barker,
Alanna Lmussawwir Bias,
Amanda S Zorn,
Andrea J Schmidt,
Andrew M Kolenc,
Barbara J White,
Betty K Baxter,
Brent W Higgs,
Brittany R Laymon,
Bryan J Love,
Bryce A Hammer,
Carla R Hinz,
Carolyn J Cook,
Chet A Fitzgerald,
Christine I Shaw,
Christine L Williams,
Christopher J Freebairn,
Courtney R Bratina,
Craig A Stoflet,
Cynthia Jim, CSO,
Daniel J Lahar,
David A Gonzalez,
Deborah S Hammond,
Debra L Curtis,
Dianna D Wardlow Dotter,
Dr. Abhijit Raha, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Duc Minh H Nguyen,
Elisa J Beard,
Emily B Camire,
Felix J Marrero,
Gary C Pecic,
Gerard T Schneider,
Ginger M Sykes,
Gloria A Milster,
Grace E Mcnally,
Hanna L Potter,
Haroon Vohra (NMI),
Holly L Miller,
Isabel Y Espinosa,
Isaiah D Isakson,
Ismael Olvera, IV,
James D Romero,
James R Montero,
Jamie L Dion,
Jennifer A Baker,
Jennifer A Robinson,
Jennifer R Mathern,
Jessica M Ector,
Jessie E Morris,
Joan A Loreng,
Jonathan R Campos,
Julia D Cartwright,
Kathleen S Tormey,
Kathryn M Mogen,
Keith C Littrell,
Kelly D Moore,
Kimberley A Hoefen,
Kristen E Szenderski,
Larisa E Pavlick,
Larry Gehring,
Laura B Kennedy,
Laura L Van Wagenen,
Lavender M Huskey,
Lillie M Young,
Linda F Murphy,
Linda M Cheny,
Lori A Carr,
Manuel A Moreno,
Marc A Jackson, Jr,
Marie Bbuen Bigornia,
Marion W Nadeau,
Marsha L Mccauley,
Martina E Lagrange,
Mary F Bodick,
Mary T Carden,
Matthew A Johnson,
Matthew A Kozler,
Matthew R Dionne,
Meaghan M Rabideau,
Melisa A Healy,
Michael D Vansickle,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Mitzi A Schwertfeger,
Nathan M Jornod,
Nathan R Moon,
Nayan J Patel,
Nicole J Clausen,
Oluwaseyi Ojinni,
Patricia A Brown,
Patricia A Maestas,
Patricia M Jacobs,
Paul J Teitell,
Paul M Chefor,
Paul Z Balcer,
Rafael H Ortiz,
Randy V Bong,
Ricki A Chase,
Ruth A Williams,
Sheila Alaghemand,
Shererk,
Solomon G Williams,
State Agency,
Stephen T Hansen,
Steven O Gauthier,
Teena H Aiken,
Tenzin Jangchup,
Theressa B Smith,
Travis S Bradley,
Tricia S Martinez,
William F Lagud, Jr,
Zachary L Miller,
Zachary L Stamm
Daniel Pst Laurent's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2013 | FDA 483 | Eastern Colorado Health Care System - Form 483, 2013-01-14 |
October, 2012 | FDA 483 | CSL Plasma, Inc. - Form 483, 2012-10-19 |
October, 2012 | EIR | CSL Plasma, Inc. - EIR, 2012-10-19 |
January, 2013 | EIR | Eastern Colorado Health Care System - EIR, 2013-01-14 |
March, 2013 | FDA 483 | CSL Plasma Inc. - Form 483, 2013-03-01 |
April, 2010 | FDA 483 | Barke, Lora D., D.O. - Form 483, 2010-04-15 |
May, 2012 | EIR | Children's Hospital Colorado - EIR, 2012-05-15 |
November, 2009 | FDA 483 | BioCentric Labs Inc - Form 483, 2009-11-13 |
March, 2013 | FDA 483 Response | CSL Plasma Inc. - Form 483R, 2013-03-15 |
March, 2013 | EIR | CSL Plasma Inc. - EIR, 2013-03-01 |
December, 2011 | EIR | Lynn R. Webster, MD - EIR, 2011-12-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more